The connection between multiple sclerosis and Epstein-Barr virus (EBV) is strengthening, according to a paper published this ...

The connection between multiple sclerosis and Epstein-Barr virus (EBV) is strengthening, according to a paper published this week in JAMA Neurology by a team of international researchers, including a ...

Wikimedia Commons. The Epstein-Barr virus (EBV) is so common that most people pick it up at some point, often as “mono,” and then forget abo ...

New research advances an Epstein–Barr virus vaccine, while another study detects higher levels of microplastics in prostate cancer tumors.

Persistence of high EBNA-1 titers across longitudinal samples was characteristic of MS, whereas MOGAD and NMOSD generally exhibited titer attenuation during follow-up. High-level EBNA-1 positivity in ...

Announced data from cohort 4 of soquelitinib atopic dermatitis Phase 1 trial demonstrating positive safety and efficacy results, including in ...

A multi-disciplinary research team at the Wyss Institute at Harvard University, Dana-Farber Cancer Institute, and ...

Immunic Therapeutics was granted a patent in Europe that protects all dosing regimens of its MS therapy vidofludimus calcium through 2038.

Bavarian Nordic AS (BVNKF) reports robust revenue growth and strategic expansions, despite challenges in vaccine shelf life and increased expenses.

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...